ESMO 2024: Dr. Erika Hamilton on Trastuzumab and HER2 Testing Insights

In this video, Dr. Erika Hamilton highlights the latest data on trastuzumab and HER2 testing presented at ESMO 2024. She provides valuable insights into recent advancements and their implications for treatment strategies in HER2-positive cancers.